Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 541-550 of 1760 for

Edit search filters
  1. Lenalidomide Or Observation In Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

    Rochester, MN

  2. Ixazomib Citrate, Lenalidomide, And Dexamethasone In Treating Patients With POEMS Syndrome

    Rochester, MN

  3. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) In Cutaneous Stage L-lll Melanoma

    Rochester, MN

  4. Hypo-fractionated Radiation Therapy With Or Without Androgen Suppression For Intermediate Risk Prostate Cancer

    Scottsdale/Phoenix, AZ

  5. S1304, Carfilzomib And Dexamethasone For Treating Patients With Relapsed Or Refractory Myeloma

    Jacksonville, FL, Rochester, MN

  6. A Study Of Afatinib Treatment For Patients With Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 Or Older

    Scottsdale/Phoenix, AZ

  7. A Dose Escalation Study Of HFB301001 In Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. E6201 Plus Dabrafenib For The Treatment Of Metastatic Melanoma Central Nervous System Metastases (CNS)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Brightline-1: A Study To Compare Bi 907828 With Doxorubicin In People With A Type Of Cancer Called Dedifferentiated Liposarcoma

    Jacksonville, FL, Rochester, MN

  10. Tebentafusp Regimen Versus Investigator's Choice In Previously Treated Advanced Melanoma (TEBE-AM)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer